Lifevit participates in the largest telemedicine study on heart failure in Spain.

The Lancet Digital Health has published the results of the HERMeS trial.

A pioneering study led by the Bellvitge University Hospital (IDIBELL) and the CIBER Network Biomedical Research Center confirms that the combination of telemonitoring and teleintervention reduces decompensation and mortality in patients with heart failure.

The technological solution included the use of connected devices such as the LifeVit smart scale, which enabled accurate remote daily monitoring.

This is clear evidence of the value that technology brings to healthcare and proactive prevention, improving both patient quality of life and the sustainability of the healthcare system.

At LifeVit, we remain committed to innovation in digital health to improve people’s quality of life and the efficiency of the healthcare system.

https://bellvitgehospital.cat/ca/actualitat/noticia/la-telemedicina-redueix-fins-un-54-la-mortalitat-cardiovascular-en-insuficiencia